FHPR is characterized by short stature, intractable hypophosphatemia and rickets. This proposal is part of a multiinstitutional pilot investigation of the effects of growth hormone therapy on phosphate balance and growth rate in children and adults with FHPR.
Showing the most recent 10 out of 837 publications